34900 Federal Register / Vol. 63, No. 123 / Friday, June 26, 1998 / Notices

must any other action that an Environmental

Assessment (EA) indicates may have

significant environmental effects:

• Master plans for Federally owned major

buildings, building complexes, and sites

(Note: EIS should be designed so that

subsequent EISs and EAs can be tiered off it).

• Acquisition of space by Federal

construction or lease construction, or

expansion or improvement of an existing

facility, where one or more of the following

applies:

—The structure and/or proposed use are not

substantially consistent with local

planning and zoning or any applicable

State or Federal requirements.

—The proposed use will substantially

increase the number of motor vehicles at

the facility.

—The site and scale of construction are not

consistent with those of existing adjacent

or nearby buildings.

—There is evidence of current or potential

community controversy about

environmental justice or other

environmental issues.

• Space acquisition programs projected for

a substantial geographical area (e.g., a

metropolitan area) for a 3-to-5-year period or

greater (Note: a PEIS is often appropriate

here, off which subsequent EISs and EAs can

be tiered).

[FR Doc. 98–16304 Filed 6–25–98; 8:45 am]

BILLING CODE 6820–BR–U

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Meeting of the National Bioethics

Advisory Commission (NBAC)

SUMMARY: Pursuant to section 10(d) of

the Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is given of a meeting of the National

Bioethics Advisory Commission. The

Commission will continue addressing

(1) The protection of the rights and

welfare of human subjects in research

including research involving persons

with mental disorders affecting

decisionmaking capacity, (2) issues in

the research use of human biological

materials, and (3) a proposed project on

the ethical and legal issues in

international research supported and/or

conducted by the United States. The

Commission also plans to hear

presentations on the ethical principles

expressed in the seminal Belmont

Report, the Inspector General’s Report

on Institutional Review Boards, and

research concerns in Native American

communities. The meeting is open to

the public and opportunities for

statements by the public will be

provided on July 15, 1998 from 11:30

am to 12 Noon.

Dates/Times:

July 14, 1998, 1:00 pm–5:00 pm and

July 15, 1998 8:00 am—5:00 pm.

Location:

Oregon Ballroom, Salon F, Portland

Marriott, and 1401 Naito Parkway,

Portland, Oregon.

SUPPLEMENTARY INFORMATION: The

President established the National

Bioethics Advisory Commission (NBAC)

on October 3, 1995 by Executive Order

12975 as amended. The mission of the

NBAC is to advise and make

recommendations to the National

Science and Technology Council, its

Chair, the President and other entities

on bioethical issues arising from the

research on human biology and

behavior, and from the applications of

that research and makes its

recommendations available to the

public.

Public Participation

The meeting is open to the public

with attendance limited by the

availability of space on a first come, first

serve basis. Members of the public who

wish to present oral statements should

contact Ms. Patricia Norris by

telephone, fax machine, or mail as

shown below at least 4 days before the

meeting and as soon as possible. The

Chair will reserve time for presentations

by persons requesting to speak and

requests that oral statements be limited

to five minutes . The order of persons

wanting to make a statement will be

assigned on a first come, first serve

basis. Individuals unable to make oral

presentations can mail or fax their

comments to the NBAC staff office at

least five business days prior to the

meeting for distribution to the

Commission and inclusion in the public

record. The Commission also accepts

general comments at its website at

bioethics.gov. Persons needing special

assistance, such as sign language

interpretation or other special

accommodations, should contact NBAC

staff at the address or telephone number

listed below as soon as possible.

FOR FURTHER INFORMATION CONTACT: Ms.

Patricia Norris, National Bioethics

Advisory Commission, 6100 Executive

Boulevard, Suite 5B01, Rockville,

Maryland 20892–7508, telephone 301–

402–4242, fax number 301–480–6900.

Henrietta D. Hyatt-Knorr,

Deputy Executive Director, National Bioethics

Advisory Commission.

[FR Doc. 98–16623 Filed 6–25–98; 8:45 am]

BILLING CODE 4160–17–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 98046]

National Comprehensive Cancer

Control Program; Notice of Availability

of Funds for Fiscal Year 1998;

Amendment

A notice announcing the availability

of Fiscal Year 1998 funds for

cooperative agreements to implement

comprehensive cancer control plans was

published in the Federal Register on

May 13, 1998, (63 FR 26614). The notice

is amended as follows:

On page 26614, in the announcement

title, Announcement number is changed

to 99046.

On page 26614, third column, under

the heading Availability of Funds the

first paragraph should read:

Approximately $1.5 million is available

in FY 1999 to fund approximately 5

awards * * * Line seven should read:

on or about October 30, 1998 * * *.

On page 26619, under the heading

Application Submission and Deadline

the first paragraph should read: The

original and two copies of the

completed CDC 0.1246 must be

submitted to * * * on or before July 27,

1998.

On page 26619, under the heading

Where to Obtain Additional

Information, the third paragraph should

read: Please refer to Program

Announcement Number 99046 when

requesting information and submitting

an application.

On page 26620, under the heading

Eligibility Assurance Form, the third

subparagraph, on the third line should

read: an up-to-date detailed final draft

ready for implementation by October 30,

1998.

All other information and

requirements of the notice remain the

same.

Dated: June 22, 1998.

Joseph R. Carter,

Acting Associate Director for Management

and Operations, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 98–17089 Filed 6–25–98; 8:45 am]

BILLING CODE 4163–18–M